Study of rare bone disease reaches important milestone

Progress by a UMass Chan Medical School researcher in developing a gene therapy for a rare, crippling bone disease has reached an important milestone with demonstration of proof-of-concept in a humanized mouse model of fibrodysplasia ossificans progressiva (FOP) and human FOP patient-derived cells. The research is published in Nature Communications.